ArticleFrontiers in molecular biosciences2025

SRC is a potential target of Arctigenin in treating triple-negative breast cancer: based on machine learning algorithms, molecular modeling and

Yuezhou Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.